Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Union
Pharma
ARS inks ex-US licensing pact for Neffy worth up to $465M
ARS will receive up to $465 million in a new licensing pact with ALK-Abelló to sell its epinephrine nasal spray Neffy in certain ex-U.S. territories.
Fraiser Kansteiner
Nov 11, 2024 9:44am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
EU regulator calls for withdrawal of certain preterm birth drugs
May 17, 2024 10:37am
Lady Gaga's post about Pfizer Nurtec ODT ad earns EU ire
Apr 12, 2024 12:07pm
Biogen and Reata build their blockbuster case for Skyclarys
Feb 12, 2024 5:05pm
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
